about
An efficient strategy to induce and maintain in vitro human T cells specific for autologous non-small cell lung carcinomaAnti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity.A novel self-lipid antigen targets human T cells against CD1c(+) leukemiasStore-operated Ca2+ entry does not control proliferation in primary cultures of human metastatic renal cellular carcinoma.PaCS is a novel cytoplasmic structure containing functional proteasome and inducible by cytokines/trophic factors.Innovative approaches of adoptive immune cell therapy in paediatric recipients of haematopoietic stem cell transplantation.Expansion of antileukaemia CTL lines and clones for adoptive cell therapy in paediatric patients given allogeneic haematopoietic stem cell transplantation.Interleukin-27 inhibits the growth of pediatric acute myeloid leukemia in NOD/SCID/Il2rg-/- mice.Direct inhibition of human acute myeloid leukemia cell growth by IL-12.Constitutive Store-Operated Ca(2+) Entry Leads to Enhanced Nitric Oxide Production and Proliferation in Infantile Hemangioma-Derived Endothelial Colony-Forming Cells.Ex vivo generation and expansion of anti-tumor cytotoxic T-cell lines derived from patients or their HLA-identical sibling.Generation and ex vivo expansion of cytotoxic T lymphocytes directed toward different types of leukemia or myelodysplastic cells using both HLA-matched and partially matched donors.Ex vivo priming for long-term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapy.Alterations of in vitro interleukin 1 and 2 in diabetic children.Antigen-specific T cell response in infants after recombinant hepatitis B virus vaccination at birth: evaluation of T helper lymphocyte diversity.Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication.Hyper IgE syndrome: anaphylaxis in a patient carrying the N567D STAT3 mutation.Safety and immunogenicity of a genetically engineered human immunodeficiency virus vaccine.The immunosuppressive effect of human cytomegalovirus infection in recipients of allogeneic hematopoietic stem cell transplantation.Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes.Interleukin-15 favors the expansion of central memory CD8+ T cells in ex vivo generated, antileukemia human cytotoxic T lymphocyte lines.Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.Case report: long-lasting response in a patient with metastatic renal cell cancer receiving antitumor cytotoxic T lymphocytes.Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.Acquired immune deficiency syndrome in childhood: impaired production of interleukin-2 by HIV (LAV/HTLV III) infected patients.Human alloantigen-specific anergic cells induced by a combination of CTLA4-Ig and CsA maintain anti-leukemia and anti-viral cytotoxic responsesFunctional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsetsAn improved PCR-heteroduplex method permits high-sensitivity detection of clonal expansions in complex T cell populationsFeasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumorInvariant NKT Cell Reconstitution in Pediatric Leukemia Patients Given HLA-Haploidentical Stem Cell Transplantation Defines Distinct CD4 + and CD4 − Subset Dynamics and Correlates with Remission StateEmergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemiaNotch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemiaIn vivo activated cord blood lymphocytes express high affinity interleukin-2 receptor: evaluation of their responsiveness to in vitro stimulation with recombinant interleukin-2Cell-mediated cytotoxicity in Down syndrome: impairment of allogeneic mixed lymphocyte reaction, NK and NK-like activitiesLymphocyte subpopulations in the neonate: a subset of HNK-1-, OKT3-, OKT8+ lymphocytes displays natural killer activityFrequency of donor cytotoxic T cell precursors does not correlate with occurrence of acute graft-versus-host disease in children transplanted using unrelated donorsExpression of CD45R0 antigen on the surface of resting and activated neonatal T lymphocyte subsetsMarked and sustained improvement 2 years after autologous stem cell transplantation in a girl with systemic sclerosisAnalysis of immune reconstitution in children undergoing cord blood transplantationMarked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis
P50
Q28749871-E6E8E831-954A-4DE6-B5D9-0A762249DEEEQ33378871-452CC1F5-D249-4E58-B892-1F6DE04283C4Q33826848-02EFE87F-91E0-434B-974A-07C1A17E1D0AQ33994049-3AC74B54-E300-40DB-92B7-6C6237AB2BB4Q35072849-FF6C4A2D-194E-473A-B848-209B0DBA4FC1Q35925040-A4FFA47D-3392-410E-ABE6-9B906F298BA8Q37314345-072A875F-66C6-41B6-922F-F6E445FFAB34Q39645765-92464994-29A5-4C42-AAF5-976E8C8214C7Q39668237-C981FA44-B69C-4271-B1F1-7F05982C922FQ40225737-26433276-4FFC-4D42-B1B6-134385B55193Q40571600-F9286745-37CC-42D9-BD3A-E4119A5839B8Q40621628-7547FF09-C817-4928-AA9C-342B3579E104Q40766986-0E6A7612-A165-4B40-A0EF-97E0325F1E9CQ41327074-3AD5B394-3144-46AE-807D-604ADB39C2B7Q45723479-919402F1-7A06-4E53-A920-11FED06658CFQ45733331-62188285-BBA4-4E43-A77E-BAB1BAC85904Q45853203-FF31F36A-C14D-4C0A-AB93-B3676A56B49BQ45853305-1556B960-B648-4F2C-A33D-C6812005CBC4Q46592687-B399D243-E169-4451-96A9-A6663C63DB35Q46843423-EBD38DA7-575A-462B-B55D-921301718020Q51965820-5CDD26A0-9925-4E50-9997-D7DC84B3F3F6Q53328521-E0659AE3-516B-4E42-959D-F1F3194AA8E8Q54312350-06E9064F-04EB-4813-AE87-D3C7E758D71AQ54510650-4EB54849-C9FC-4F23-8E40-9F2D2704F489Q55243118-535D3644-5C75-4555-86E2-1E94DF6A38ABQ56905154-2359A156-A9DC-48AB-9F2C-C8E5E3B7E4B5Q56987951-F749243D-01EC-4FDE-B98A-2797D0BCE5A9Q56988065-AD8A65A2-09F2-4670-ACC6-5B6609A56649Q60589807-2FD9E238-FEBC-4218-9BAE-3CD331493647Q61048279-437873E8-9AF8-45F2-BAE6-C438539D63DCQ61048365-56046A49-28F3-433C-B976-B09B0A5A2AF2Q63356670-AAD162AE-A079-42A6-9E59-CC6E471846D1Q67974448-9C95E5AC-7609-4E3C-AF84-87FF5AE253AFQ70065684-CF20D393-6F7F-488F-966E-BC79040D8467Q70337984-DCA19153-1A8E-4542-99B0-5B4DCA080415Q71216888-1FA66538-B8CA-4FA8-BB97-D45539EB879DQ72720287-B54795EB-D2B6-4FF9-A962-E516FDCC412EQ73029408-2B635745-8E0A-4351-8F9E-AA041E751BDBQ73685784-7282AE41-534E-44C3-8DE8-2FD2F296C42DQ77352574-34C0D65C-A364-49D6-83B4-BDD04E66FC90
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-1533-579X
@en
name
Daniela Montagna
@ast
Daniela Montagna
@en
Daniela Montagna
@es
Daniela Montagna
@nl
type
label
Daniela Montagna
@ast
Daniela Montagna
@en
Daniela Montagna
@es
Daniela Montagna
@nl
prefLabel
Daniela Montagna
@ast
Daniela Montagna
@en
Daniela Montagna
@es
Daniela Montagna
@nl
P106
P1153
7004299240
P21
P31
P496
0000-0002-1533-579X